These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission. Gatti G, Perucca E, Frigo GM, Notarangelo LD, Barberis L, Martini A. Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988 [Abstract] [Full Text] [Related]
6. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Powell LW, Axelsen E. Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403 [Abstract] [Full Text] [Related]
7. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease. Thomas P, Richards D, Richards A, Rogers L, Evans BK, Dew MJ, Rhodes J. J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153 [Abstract] [Full Text] [Related]
17. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K. Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270 [Abstract] [Full Text] [Related]
18. Bioavailability and reversible metabolism of prednisone and prednisolone in man. Garg V, Jusko WJ. Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967 [Abstract] [Full Text] [Related]